Eli Lilly’s Retatrutide Outpaces Ozempic on Weight Loss in First Head-to-Head Trial

Retatrutide cut A1C by 2.2 points and weight by roughly 20% in an 80-week trial of 1,298 adults with type 2 diabetes, against 1.8 points...
Thursday, October 29, 2026, 12:14:43 AM

Related News

Can Ozempic Topple Fast Food Demand?
FDA Approves Wegovy Competitor from Eli Lilly

Flávio Bolsonaro Says He Left Brazil but Did Not Flee, Vows to Direct Opposition from the US

A Brazilian diplomat says Bolsonaro entered Argentina on an Italian passport. Workers' Party lawmakers have...
Thursday, October 29, 2026, 12:01:05 AM

Agnico Eagle Q3 Free Cash Flow Falls 36% to US$852 Million as Costs Climb

Agnico Eagle Mines (TSX: AEM) posted third quarter net income of US$1.35 billion, or US$2.67...

Wednesday, October 28, 2026, 11:09:37 PM

Bank of Canada Lifts Policy Rate to 2.5%, Flags Further Hikes

A tightening campaign with few signs of letting up gained fresh momentum on Wednesday as...

Wednesday, October 28, 2026, 10:00:06 AM

This Copper Mine Costs 1/6 to Restart | SSR Mining X Roxmore

SSR Mining has agreed to acquire Roxmore Resources for US$464 million in cash, securing the...

Sunday, October 25, 2026, 01:31:00 PM
Video Articles

This Copper Mine Costs 1/6 to Restart | SSR Mining X Roxmore

Why Cambria Hit Pause on Its Massive Copper-Gold Spinout

Can Gold Rescue Washington From Its Debt Trap? | Andy Schectman – Miles Franklin

Recommended

Mercado Minerals Lengthens El Triunfo Vein by 190 Metres, Readies 1,500-Metre Zamora Drill Program

Blue Jay Gold Signs Ocean Partners Deal to Ship Steller Stockpiles Through 2027